Ag Novartis - Net Worth and Insider Trading
Ag Novartis Net Worth
The estimated net worth of Ag Novartis is at least $982 Million dollars as of 2024-12-27. Ag Novartis is the 10% Owner of Alnylam Pharmaceuticals Inc and owns about 4,051,002 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $982 Million. Details can be seen in Ag Novartis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ag Novartis has not made any transactions after 2012-09-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ag Novartis
Ag Novartis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ag Novartis owns 24 companies in total, including Cellular Biomedicine Group Inc (CBMG) , Poseida Therapeutics Inc (PSTX) , and Akouos Inc (AKUS) among others .
Click here to see the complete history of Ag Novartis’s form 4 insider trades.
Insider Ownership Summary of Ag Novartis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CBMG | Cellular Biomedicine Group Inc | 2020-08-11 | 10 percent owner |
| PSTX | Poseida Therapeutics Inc | 2020-07-09 | 10 percent owner |
| AKUS | Akouos Inc | 2020-06-25 | 10 percent owner |
 | | 2020-06-18 | 10 percent owner |
| | 2019-11-06 | 10 percent owner |
| | 2019-05-22 | 10 percent owner |
| | 2019-04-25 | 10 percent owner |
| | 2017-06-28 | 10 percent owner |
| | 2018-12-31 | 10 percent owner |
| | 2017-05-04 | 10 percent owner |
| | 2018-05-15 | 10 percent owner |
| | 2016-04-06 | 10 percent owner |
| | 2018-04-18 | 10 percent owner |
| | 2018-03-27 | 10 percent owner |
| | 2017-06-16 | 10 percent owner |
| | 2016-02-17 | 10 percent owner |
| | 2014-09-16 | 10 percent owner |
| | 2012-09-20 | 10 percent owner |
| | 2010-07-21 | 10 percent owner |
| | 2006-07-25 | 10 percent owner |
| | 2017-03-15 | 10 percent owner |
| | 2016-02-10 | 10 percent owner |
| | 2022-06-15 | 10 percent owner |
| | 2016-02-10 | 10 percent owner |
Ag Novartis Latest Holdings Summary
Ag Novartis currently owns a total of 1 stock. Ag Novartis owns 4,051,002 shares of Alnylam Pharmaceuticals Inc (ALNY) as of September 20, 2012, with a value of $982 Million.
Latest Holdings of Ag Novartis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2012-09-20 | 4,051,002 | 242.50 | 982,367,985 |
Holding Weightings of Ag Novartis
Ag Novartis Form 4 Trading Tracker
According to the SEC Form 4 filings, Ag Novartis has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 1,551,896 shares on September 20, 2012, which brought Ag Novartis around $30 Million.
Insider Trading History of Ag Novartis
- 1
Ag Novartis Trading Performance
GuruFocus tracks the stock performance after each of Ag Novartis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ag Novartis is 5.78%. GuruFocus also compares Ag Novartis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ag Novartis within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ag Novartis's insider trading performs compared to the benchmark.
Performance of Ag Novartis
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.57 | | | | | |
| Relative Return to S&P 500(%) | 11.78 | | | | | |
Ag Novartis Ownership Network
Ag Novartis Owned Company Details
What does Cellular Biomedicine Group Inc do?
Who are the key executives at Cellular Biomedicine Group Inc?
Ag Novartis is the 10 percent owner of Cellular Biomedicine Group Inc. Other key executives at Cellular Biomedicine Group Inc include 10 percent owner Pharma Ag Novartis , 10 percent owner Maplebrook Ltd , and 10 percent owner Sailing Capital Overseas Investments Fund, LP .
Cellular Biomedicine Group Inc (CBMG) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cellular Biomedicine Group Inc (CBMG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cellular Biomedicine Group Inc (CBMG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cellular Biomedicine Group Inc (CBMG)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cellular Biomedicine Group Inc Insider Transactions
Ag Novartis Mailing Address
Above is the net worth, insider trading, and ownership report for Ag Novartis. You might contact Ag Novartis via mailing address: Lichtstrasse 35, Basel V8 Ch 4056.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
